About Careers Internship MedBlog Contact us

Cancer Cells Fuel Prostate Cancer

by Medindia Content Team on October 12, 2007 at 8:52 PM
Cancer Cells Fuel Prostate Cancer

The study, conducted by Peter Nelson, M.D., Elahe Mostaghel, M.D., Ph.D., and Bruce Montgomery, M.D. from the Fred Hutchinson Cancer Research Center and University of Washington, suggests that cancer cells may develop the capacity to produce their own androgens with the help of the androgen-synthesizing proteins.

In the study, tests were conducted on tumours removed and preserved from deceased prostate cancer patients during "rapid autopsies" immediately after death.


During the course of treatment all the patients had received androgen-blocking therapies to suppress tumour growth.

The analysis made the team detect the key proteins in the tumours, or enzymes, needed for a cell to produce its own testosterone from cholesterol present in the cell.

"This study, along with other research in the field, suggests that cancer cells may have the ability to adapt and produce their own androgens that permit these cancer cells to survive," said Nelson.

"While this study does not prove that the cancer cells act in this way, it does show it is possible," he added.

In order to deprive cancer cells of the hormones that fuel their growth androgen-deprivation therapy is routinely used in the treatment of advanced (metastatic) prostate cancer.

However, cancer cells become 'androgen independent' over time and grow even in the presence of the medications.

New medications are being clinically tested with the goals of blocking androgen synthesis.

Abiraterone, for example, inhibits the enzymes in the metabolic pathways, which convert cholesterol to androgens, and work by blocking androgen synthesis in adrenal gland and possibly in the tumours themselves

Source: ANI
Font : A-A+



Recommended Readings

Latest Cancer News

Novel Photo-Oxidation Therapy Holds Promise for Anticancer Treatment
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 Genes Linked to Aggressive Prostate Cancer
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Link Between Poor Oral Health and Head & Neck Cancer Survival Uncovered
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
Painless Lumps in the Body May Signal Lymphatic Cancer Risk
The presence of painless swelling in the lymph nodes could potentially indicate lymphatic cancer, say experts.
Non-clinical Genetic Testing May Lead to Needless Breast Surgery
Women tested at high risk for breast cancer using non-clinical genetic tests overlooking family history may decide to undergo unnecessary breast surgery.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Cancer Cells Fuel Prostate Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests